Hiroshi Kaetsu

Title: Hiroshi Kaetsu: Innovator in Hemostatic Solutions

Introduction

Hiroshi Kaetsu is a prominent inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic solutions. With a total of five patents to his name, Kaetsu's work focuses on improving clinical applications for fibrinogen and thrombin.

Latest Patents

One of Kaetsu's latest patents is a solid fibrinogen preparation. This innovative preparation boasts improved solubility and can be rapidly utilized in clinical settings. It comprises fibrinogen as the main ingredient, along with albumin, a nonionic surfactant, a basic amino acid or its salt, and a combination of at least two amino acids selected from acidic and neutral categories. This solid fibrinogen composition can be integrated with medical materials to create a supporting structure that holds fibrinogen. Additionally, it can be combined with thrombin to produce a fibrin adhesive.

Another notable patent is the bioabsorbable synthetic nonwoven fabric holding thrombin. This invention provides a safe and effective hemostatic solution. The process involves immersing a bioabsorbable synthetic nonwoven fabric in a thrombin solution and lyophilizing the fabric. This innovative fabric allows for quicker and more effective hemostasis, enhancing patient outcomes in medical procedures.

Career Highlights

Hiroshi Kaetsu has worked with esteemed organizations such as the Juridical Foundation the Chemo-Sero-Therapeutic Research Institute and The Chemo-Sero-Therapeutic Research Institute. His experience in these institutions has significantly contributed to his expertise in medical innovations.

Collaborations

Kaetsu has collaborated with notable colleagues, including Takanori Uchida and Noriko Shinya. Their combined efforts have further advanced the development of effective medical solutions.

Conclusion

Hiroshi Kaetsu's contributions to the field of hemostatic solutions demonstrate his commitment to improving medical technology. His innovative patents and collaborations highlight his role as a key figure in advancing clinical applications.